Align Biopharma to create open technology standards that make it
faster and easier for healthcare professionals to connect with life
sciences companies
NEW YORK--(BUSINESS WIRE)--
Veeva
Systems Inc. and six of the top 25
largest global pharmaceutical companies today announced the formation of Align
BiopharmaTM, a new group dedicated to setting technology
standards that will make it faster and easier for healthcare
professionals (HCPs) to connect with the life sciences industry.
Founding members, with input from across the industry, will develop open
standards and solutions for companies to streamline how HCPs get the
drug and treatment information they need to deliver improved care to
patients.
“Common industry standards can make it more effective and efficient for
life sciences companies and healthcare professionals to connect,” said
Patrick Retif, VP IT, Global Commercial at Allergan. “Working together
can help harmonize digital engagement and information access across the
industry and create a better experience for our shared customers.”
The rise of specialty drugs to treat complex diseases is creating a
greater need for HCPs to have more timely and tailored information. As
the number of new drugs increases so does the amount of information
healthcare professionals require to facilitate patient engagement. There
is significant potential for biopharmaceutical companies to use digital
technology to inform HCPs on new or more complex treatments.
Initially, Align Biopharma will focus on developing two new standards to
facilitate seamless digital engagement and simplify the HCP experience:
-
Identity management – definition of an identification and
authentication standard to enable a single sign-on for HCPs to access
online content – including websites, portals, virtual events, or
webinars – across all companies.
-
Consent and communication preferences – definition of standards
for consent and preference management so that there is consistency in
how HCPs specify communication preferences with each company.
“Digital is transforming how life sciences companies and HCPs
collaborate and interact,” said Paul Shawah, vice president of
commercial cloud strategy at Veeva. “With the proliferation of advanced
treatments and digital channels, adhering to industry standards will
simplify the challenges doctors face in getting the right information
quickly.”
For more information on Align Biopharma, visit AlignBiopharma.org
to learn about its mission and current standards in development.
About Align Biopharma
Align Biopharma is an industry standards group comprised of leading
pharmaceutical companies dedicated to making it faster and easier for
healthcare professionals to connect with the life sciences industry and
get the drug and treatment information they need to deliver improved
care to patients. For more information, visit AlignBiopharma.org.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170111005301/en/
Source: Veeva Systems Inc.